cpi-0209

Small moleculeexperimental

Chemistry & pharmacology

Loading structure…

SMILES

COC1CN([C@H]2CC[C@H]([C@@]3(C)Oc4c(Cl)cc(C(=O)NCc5c(SC)cc(C)[nH]c5=O)c(C)c4O3)CC2)C1
Mol. weight
562.13 g/mol
Lipinski Ro5
1 violation(s)
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07190300Phase 1/Phase 2 (Phase 2)Nov 24, 2025Novartis
NCT07206056Phase 1/Phase 2 (Phase 2)Oct 15, 2025Novartis
NCT05942300Phase 1Dec 31, 2023MorphoSys, National Cancer Institute (NCI), University of Pittsburgh
NCT05944562Phase 1Dec 31, 2023MorphoSys, Novartis, Swim Across America, Washington University in St. Louis
NCT04104776Phase 1/Phase 2 (Phase 2)Sep 18, 2019Constellation Pharmaceuticals
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
NovartisFor profit3222023
MorphoSysFor profit2012023
Constellation PharmaceuticalsFor profit1112019
National Cancer Institute (NCI)Government1012023
Swim Across AmericaAcademic/Hospital1012023
University of PittsburghAcademic/Hospital1112023
Washington University in St. LouisAcademic/Hospital1112023
7 organizations
Page 1 / 1